Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers.
about
Oral administration of beta-1,3/1,6-glucan to dogs temporally changes total and antigen-specific IgA and IgMImmune-modulatory effects of dietary Yeast Beta-1,3/1,6-D-glucan.Hochuekkito, a Kampo (Traditional Japanese Herbal) Medicine, and its Polysaccharide Portion Stimulate G-CSF Secretion from Intestinal Epithelial CellsImmunomodulatory dietary polysaccharides: a systematic review of the literatureThe effects of beta-glucan on human immune and cancer cells.Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responsesImprovement in Human Immune Function with Changes in Intestinal Microbiota by Salacia reticulata Extract Ingestion: A Randomized Placebo-Controlled Trialβ-Glucan supplementation, allergy symptoms, and quality of life in self-described ragweed allergy sufferers.Do cereal mixed-linked β-glucans possess immune-modulating activities?Effects of orally administered yeast-derived beta-glucans: a review.Immunological actions of Sophy beta-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement.A randomized, single-blind, parallel-group clinical study to evaluate the effect of soluble beta-1,3/1,6-glucan on experimental gingivitis in man.Scientific Opinion on the substantiation of a health claim related to Yestimun® and immune responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006Scientific Opinion on the safety of ‘yeastbeta-glucans’ as a Novel Food ingredientScientific Opinion on the substantiation of a health claim related to Yestimun®and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen.
P2860
Q28268672-B092B8AD-B9F2-4728-94D9-0AEAAD7BF288Q33574573-BA5EA739-F7AA-4EE2-B24D-C2F776E8EAC5Q33919728-097F3FE1-A374-4AE5-84AB-33B91C023745Q34150565-D2F90C8B-E01A-49A2-85B1-F5D4F1F511FBQ34608777-00D23AB8-CC67-4537-8FB0-1A2CD4247D5AQ35127314-4AD6FD6F-3748-4085-A44C-204DC8F3D5E1Q35859170-57B335D8-3A16-4A5C-A5CE-264A06F0A61FQ37633371-A144FA9E-D29C-48FD-966C-955FB33F6E33Q38001979-D44A2DFA-6FFD-457E-B649-07B9E0FC9C96Q38135766-1186990F-163F-453E-BDAF-83ACD65BA943Q40076208-A2884FA6-7D9B-4D3F-8087-33946A023C9EQ43934721-BFC98B36-AE57-4B69-BA31-7CF085D123EAQ47148380-49D2104F-AC94-45EB-9FC0-9418C390985CQ47149920-06A2CEA7-99EC-4C74-8945-3F4501620C7AQ47153150-67EEB444-614E-4920-A2D4-20717D9B97B9Q51342236-57EAB595-A6E4-448F-BD61-5AF515664DEE
P2860
Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Oral administration of a new s ...... bulin A in healthy volunteers.
@ast
Oral administration of a new s ...... bulin A in healthy volunteers.
@en
type
label
Oral administration of a new s ...... bulin A in healthy volunteers.
@ast
Oral administration of a new s ...... bulin A in healthy volunteers.
@en
prefLabel
Oral administration of a new s ...... bulin A in healthy volunteers.
@ast
Oral administration of a new s ...... bulin A in healthy volunteers.
@en
P2093
P2860
P1476
Oral administration of a new s ...... bulin A in healthy volunteers.
@en
P2093
P2860
P356
10.1111/J.1365-2249.2005.02962.X
P577
2006-01-01T00:00:00Z